Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.

Terbuch A, Posch F, Bauernhofer T, Pichler M, Peinsith H, Szkandera J, Riedl J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Stotz M, Gerger A.

Anticancer Res. 2019 Oct;39(10):5589-5596. doi: 10.21873/anticanres.13753.

PMID:
31570454
2.

Special Issue on Molecular Research Efforts in Urothelial Carcinoma: Summary of Included Topics.

Hutterer GC.

Int J Mol Sci. 2019 Aug 2;20(15). pii: E3790. doi: 10.3390/ijms20153790.

3.

BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.

Hutterer GC, Posch F, Buser L, Zigeuner R, Morshäuser L, Otto W, Wild PJ, Burger M, May M, Pichler M, Brookman-May SD.

Urol Oncol. 2019 Jul;37(7):510-518. doi: 10.1016/j.urolonc.2019.04.004. Epub 2019 May 3.

PMID:
31060796
4.

Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.

Mischinger J, Fröhlich E, Mannweiler S, Meindl C, Absenger-Novak M, Hutterer GC, Seles M, Augustin H, Chromecki TF, Jesche-Chromecki J, Pummer K, Zigeuner R.

Cent European J Urol. 2019;72(1):23-31. doi: 10.5173/ceju.2018.1858. Epub 2019 Mar 14.

5.

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. doi: 10.3390/ijms19103130.

6.

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.

Terbuch A, Posch F, Partl R, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M.

Cancer Med. 2018 Feb;7(2):508-514. doi: 10.1002/cam4.1317. Epub 2018 Jan 19.

7.

p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.

Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S.

Urol Oncol. 2018 Mar;36(3):94.e15-94.e21. doi: 10.1016/j.urolonc.2017.11.011. Epub 2017 Dec 6.

PMID:
29221641
8.

MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.

Schanza LM, Seles M, Stotz M, Fosselteder J, Hutterer GC, Pichler M, Stiegelbauer V.

Int J Mol Sci. 2017 Nov 22;18(11). pii: E2495. doi: 10.3390/ijms18112495. Review.

9.

Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.

Seles M, Posch F, Pichler GP, Gary T, Pummer K, Zigeuner R, Hutterer GC, Pichler M.

J Urol. 2017 Dec;198(6):1247-1252. doi: 10.1016/j.juro.2017.07.036. Epub 2017 Jul 14.

PMID:
28716649
10.

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.

Bezan A, Posch F, Ploner F, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Gary T, Samonigg H, Beyer J, Winder T, Hermanns T, Fankhauser CD, Gerger A, Stotz M.

PLoS One. 2017 Apr 21;12(4):e0176283. doi: 10.1371/journal.pone.0176283. eCollection 2017.

11.

Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.

Pehserl AM, Ress AL, Stanzer S, Resel M, Karbiener M, Stadelmeyer E, Stiegelbauer V, Gerger A, Mayr C, Scheideler M, Hutterer GC, Bauernhofer T, Kiesslich T, Pichler M.

Int J Mol Sci. 2016 Dec 1;17(12). pii: E2011.

12.

Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.

Dalpiaz O, Luef T, Seles M, Stotz M, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC, Pichler M.

Br J Cancer. 2017 Jan 3;116(1):85-90. doi: 10.1038/bjc.2016.393. Epub 2016 Dec 1.

13.

Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma.

Dalpiaz O, Krieger D, Ehrlich GC, Pohlmann K, Stojakovic T, Pummer K, Zigeuner R, Pichler M, Hutterer GC.

Urol Int. 2017;98(3):320-327. doi: 10.1159/000452109. Epub 2016 Oct 13.

PMID:
27732981
14.

Current Status of Long Non-Coding RNAs in Human Breast Cancer.

Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler M.

Int J Mol Sci. 2016 Sep 6;17(9). pii: E1485. doi: 10.3390/ijms17091485. Review.

15.

Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger A, Pichler M.

Int J Mol Sci. 2016 Apr 15;17(4):573. doi: 10.3390/ijms17040573. Review.

16.

Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.

Hutterer GC, Krieger D, Mrsic E, Pohlmann K, Bezan A, Stojakovic T, Pummer K, Zigeuner R, Pichler M.

Anticancer Res. 2015 Jun;35(6):3463-9.

PMID:
26026111
17.

Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.

Dalpiaz O, Pichler M, Mrsic E, Reitz D, Krieger D, Venturino L, Bezan A, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC.

J Clin Pathol. 2015 Jul;68(7):547-51. doi: 10.1136/jclinpath-2014-202683. Epub 2015 Apr 10.

PMID:
25862811
18.

Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?

Brookman-May SD, May M, Wolff I, Zigeuner R, Hutterer GC, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Feciche B, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin Mdel C, Salzano L, Lotrecchiano G, Zastrow S, Wirth M, Sountoulides P, Shariat S, Waidelich R, Stief C, Gunia S; CORONA Project; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group.

Eur Urol. 2015 May;67(5):943-51. doi: 10.1016/j.eururo.2014.11.055. Epub 2015 Feb 13.

PMID:
25684695
19.

Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.

Hutterer GC, Sobolev N, Ehrlich GC, Gutschi T, Stojakovic T, Mannweiler S, Pummer K, Zigeuner R, Pichler M, Dalpiaz O.

J Clin Pathol. 2015 May;68(5):351-5. doi: 10.1136/jclinpath-2014-202658. Epub 2015 Feb 6.

PMID:
25661796
20.

The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.

Bezan A, Mrsic E, Krieger D, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC, Pichler M.

J Urol. 2015 Jul;194(1):30-5. doi: 10.1016/j.juro.2015.01.083. Epub 2015 Jan 23.

PMID:
25623738

Supplemental Content

Loading ...
Support Center